3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
Gastrointestinal
4
Dermatologic
1
Conditions
Melanoma
33
Carcinoma, Non-Small-Cell Lung
6
Uveal Melanoma
5
Skin Neoplasms
5
Neoplasms
5
Lymphoma, T-Cell, Cutaneous
4
Kidney Neoplasms
4
Sarcoma
3
Prostatic Neoplasms
3
Mycosis Fungoides
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urticaria Pigmentosa
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Pruritus
1
Pancreatic Neoplasms
1
Interventions
Imatinib Mesylate
3
Ipilimumab
2
CTLA-4 Antigen
2
trastuzumab deruxtecan
1
ripretinib
1
pexidartinib
1
pembrolizumab
1
Thalidomide
1
Specimen Handling
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Injections
1
Fentanyl
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
Blood Specimen Collection
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Blood Specimen Collection
×
Dermatologic
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled